Abstract:Ventricular heart rate (HR) in fetal immune‐mediated third‐degree atrioventricular block (AVB III) is higher at diagnosis than later in gestation and has also been shown to decrease as a function of gestation. Our data confirms that AVB III cases detected earlier in gestation have a higher HR, and suggests that this higher HR can be successfully maintained to the end of gestation in cases treated with fluorinated steroids. We could also demonstrate that a higher HR at the end of gestation resulted in a later need for pacemaker implantation. Introduction We investigated the effects of timing of detection and transplacental fluorinated steroid treatment on ventricular heart rate (HR) and age at pacemaker implantation in fetal third‐degree atrioventricular block (AVB). Material and Methods Twenty‐five of 31 fetuses diagnosed with Ro/SSA autoantibody‐positive AVB II‐III at our tertiary fetal cardiology center (2000–2020) and AVB III as final feto‐neonatal outcome were reviewed. Results AVB was detected approximately 5 weeks earlier in pregnancy if followed in a surveillance program compared to cases referred from primary care for bradycardia (20.6 [2.3] [mean (SD)] vs. 25.4 [3.2] weeks, p = 0.001). AVB detected before 24 weeks had higher HR than those detected later in gestation (63.3 [6.9] vs. 57.2 [6.9] bpm, p = 0.042), with a larger proportion having HR >60 bpm (80% vs. 33%, p = 0.041). The 17/25 cases that received treatment with fluorinated steroid were diagnosed earlier in gestation, with higher HR at diagnosis (61.7 [7.1] vs. 54.7 [6.3] bpm, p = 0.026), 1–2 weeks after diagnosis/treatment start, and before birth (65.4 [12.4] vs. 54.9 [5.7] bpm, p = 0.030) than untreated cases. Overall, 11 cases were commenced on betamimetics: three at diagnosis and eight at or after the examination made 1–2 weeks after diagnosis/treatment start, without any HR improvement. Two of 24 surviving babies were born preterm, and 4/24 received a neonatal pacemaker. Age at pacemaker implantation correlated significantly with HR before birth (Spearman R 0.57, p = 0.004), and fetuses with HR >60 bpm had a higher rate of pacemaker‐free survival at three (90% vs. 40%, p = 0.018) and 12 months of age (80% vs. 13%, p = 0.002). The same trend was observed in pacemaker‐free survival at 3 months of age in fluorinated steroid‐treated compared to untreated cases (71% vs. 38%, ns). Conclusions Our data confirm that AVB III detected earlier in gestation have a higher HR, and suggest that this higher HR can be successfully maintained to the end of gestation in cases treated with fluorinated steroids. Fetuses with HR >60 bpm before birth had a lower rate of pacemaker implantation at 3 and 12 months of age.

Fetal bradyarrhythmias: classification, monitoring and outcomes of 40 cases at a single center

Application of Fetal Echocardiography in Detection of Fetal Arrhythmia and Its Clinical Significance

Clinical Application of Echocardiography in Detection of Foetal Arrhythmia:A Retrospective Study of 451 Foetuses

Perinatal Outcomes of Intrauterine Fetal Arrhythmias: A 10-Year Retrospective Cohort Study.

Diagnosis and the clinical significance of fetal arrhythmias

Treatment of Fetal Arrhythmias

Predisposing factors and outcome of fetal arrhythmias

Fetal Arrhythmia Diagnosis and Pharmacologic Management

"Comparing the Outcomes of Rheumatic Heart Disease in Pregnancy Complicated with and without Atrial Fibrillation: A Propensity Score Matched Analysis"

Outcome of pregnancies complicated with arrhythmias:a review of 275 patients

Maternal Cardiac Disease and Perinatal Outcomes in a Single Tertiary Care Center

Outcome of pregnancy in women with unrepaired atrial septal defect - study of a single tertiary centre

Impact of early detection and steroid treatment on fetal ventricular heart rate and pacemaker implantation in anti‐Ro/SSA positive congenital heart block

Pregnancy Outcome in Women with Rheumatic Heart Disease

Fetal arrhythmias: diagnosis and treatment

Neonatal cardiac arrhythmia: a retrospective analysis of 128 cases

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Clinical analysis of 28 cases of non benign neonatal arrhythmias

Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies

Prenatal Management Strategy For Immune-Associated Congenital Heart Block In Fetuses

Clincal Analysis of 236 Cases of Pregnancy Complicated with Cardiac Arrhythmias